Gareth Miles

Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.

Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated Tumors.

Development of a patient-derived explant model for prediction of drug responses in endometrial cancer.

Evaluating and comparing immunostaining and computational methods for spatial profiling of drug response in patient-derived explants.